Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
Open accessAbstract
Pancreatic ductal adenocarcinoma (PDAC), one of the most lethal neoplasms, is characterized by an expanded stroma with marked fibrosis (desmoplasia). We previously generated pancreas epithelium-specific TGF-β receptor type II (Tgfbr2) knockout mice in the context of Kras activation (mice referred to herein as Kras+Tgfbr2KO mice) and found that they developed aggressive PDAC that recapitulated the histological manifestations of the human disease. The mouse PDAC tissue showed strong expression of connective tissue growth factor (Ctgf), a profibrotic and tumor-promoting factor, especially in the tumor-stromal border area, suggesting an active tumor-stromal interaction. Here we show that the PDAC cells in Kras+Tgfbr2KO mice secreted much higher levels of several Cxc chemokines compared with mouse pancreatic intraepithelial neoplasia cells, which are preinvasive. The Cxc chemokines induced Ctgf expression in the pancreatic stromal fibroblasts, not in the PDAC cells themselves. Subcutaneous grafting studies revealed that the fibroblasts enhanced growth of PDAC cell allografts, which was attenuated by Cxcr2 inhibition. Moreover, treating the Kras+Tgfbr2KO mice with the CXCR2 inhibitor reduced tumor progression. The decreased tumor progression correlated with reduced Ctgf expression and angiogenesis and increased overall survival. Taken together, our data indicate that tumor-stromal interactions via a Cxcr2-dependent chemokine and Ctgf axis can regulate PDAC progression. Further, our results suggest that inhibiting tumor-stromal interactions might be a promising therapeutic strategy for PDAC.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Data from various mouse models indicate that disrupting the CXCR1/2-MDSC axis is therapeutically efficacious across a wide variety of solid cancers.
“Notably, data from various mouse models indicate that disrupting the CXCR1/2–MDSC axis in tumours is therapeutically efficacious across a wide variety of solid cancers166–172.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [169]
The relevance of targeting the CXCL1/2-S100A8/9 axis may extend beyond breast cancer.
“Moreover, the important role of CXCR2 in pancreatic adenocarcinoma models (Ijichi et al., 2011) and of S100A8/9 in colorectal cancer (Ichikawa et al., 2011) suggest that the relevance of targeting the CXCL1/2–S100A8/9 axis may extend beyond breast cancer.”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Ijichi et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439 · see citing works
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · see citing works
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969 · see citing works
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,365 · see citing works
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170 · see citing works
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,693 · see citing works
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,562 · see citing works
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471 · see citing works
Self-citationAnalysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,877 · see citing works
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1477 · Cited by 1,757 · see citing works
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515 · see citing works
TGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1926 · Cited by 1,262 · see citing works
Self-citationThe Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222 · see citing works
Warshaw, A. L., & Castillo, C. F. F.-D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202133260706 · Cited by 1,200 · see citing works
Pancreatic cancer biology and genetics
Bardeesy, N. M., & DePinho, R. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc949 · Cited by 1,144 · see citing works
Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126 · see citing works
Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1158703 · Cited by 1,033 · cited 1× · see citing works
“Importantly, inactivation of tumor suppressor genes p16INK4a (8), p53 (9, 10), or Tgfbr2 (TGF-β receptor type II) (11) dramatically accelerated PDAC progression in the context of Kras activation.”
BackgroundThe role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R. J., & Wright, C. V. E. (2002) · Nature Genetics · doi:10.1038/ng959 · Cited by 1,007 · cited 1× · see citing works
“Tgfbr2flox/flox (44) and Ptf1acre/+ (45) mice were described previously.”
BackgroundSelf-citationIntratumor microvessel density as a prognostic factor in cancer.
Weidner, N. (1995) · PubMed Central · Cited by 866 · see citing works
Connective tissue growth factor: a mediator of TGF-β action on fibroblasts
Grotendorst, G. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00010-5 · Cited by 754 · see citing works
Tumor-suppressive pathways in pancreatic carcinoma.
Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693 · see citing works
Bardeesy, N., Cheng, K.-H., Berger, J. H., Chu, G. C., Pahler, J., Olson, P., Hezel, A. F., Horner, J., Lauwers, G. Y., Hanahan, D., et al. (2006) · Genes & Development · doi:10.1101/gad.1478706 · Cited by 674 · see citing works
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Mahadevan, D., & Hoff, D. D. V. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0686 · Cited by 602 · see citing works
Bardeesy, N. M., Aguirre, A. J., Chu, G. C., Cheng, K., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C. W., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 575 · see citing works
NF-κB, chemokine gene transcription and tumour growth
Richmond, A. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri887 · Cited by 523 · see citing works
Cancer CXC chemokine networks and tumour angiogenesis
Strieter, R. M., Burdick, M. D., Mestas, J., Gomperts, B. N., Keane, M. P., & Belperio, J. A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.006 · Cited by 408 · see citing works
Izeradjene, K., Combs, C., Best, M., Gopinathan, A., Wagner, A., Grady, W. M., Deng, C.-X., Hruban, R. H., Adsay, N. V., Tuveson, D. A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.017 · Cited by 379 · see citing works
Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Fujitani, Y., Fujitani, S., Wright, C. V. E., & Moses, H. L. (2006) · Genes & Development · doi:10.1101/gad.1475506 · Cited by 379 · see citing works
Self-citationBertini, R., Allegretti, M., Bizzarri, C., Moriconi, A., Locati, M., Zampella, G., Cervellera, M. N., Cioccio, V. D., Cesta, M. C., Galliera, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402090101 · Cited by 334 · see citing works
Pancreatic Cancer Registry in Japan
Matsuno, S., Egawa, S., Fukuyama, S., Motoi, F., Sunamura, M., Isaji, S., Imaizumi, T., Okada, S., Kato, H., Suda, K., et al. (2004) · Pancreas · doi:10.1097/00006676-200404000-00002 · Cited by 307 · see citing works
Conditional inactivation of the TGF‐β type II receptor using Cre:Lox
Chytil, A. M., Magnuson, M. A., Wright, C. V. E., & Moses, H. L. (2002) · genesis · doi:10.1002/gene.10046 · Cited by 269 · see citing works
Self-citationCheng, N., Bhowmick, N. A., Chytil, A. M., Gorksa, A. E., Brown, K. A., Muraoka, R. S., Arteaga, C. L., Neilson, E. G., Hayward, S. W., & Moses, H. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208685 · Cited by 268 · see citing works
Self-citationMolecular prognostic markers in pancreatic cancer: A systematic review
Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 257 · see citing works
Forrester, E., Chytil, A., Bierie, B., Aakre, M. E., Gorska, A. E., Sharif‐Afshar, A., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 248 · see citing works
Self-citationFunction of nuclear factor kappaB in pancreatic cancer metastasis.
Fujioka, S., Sclabas, G. M., Schmidt, C., Frederick, W., Dong, Q. G., Abbruzzese, J. L., Evans, D. B., Baker, C. H., & Chiao, P. J. (2003) · PubMed · Cited by 214 · see citing works
Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia
Kojima, K., Vickers, S. M., Adsay, V. N., Jhala, N. C., Kim, H., Schoeb, T. R., Grizzle, W. E., & Klug, C. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4167 · Cited by 197 · see citing works
Brown, K. A., Aakre, M. E., Gorska, A. E., Price, J. O., Eltom, S. E., Pietenpol, J. A., & Moses, H. L. (2004) · Breast Cancer Research · doi:10.1186/bcr778 · Cited by 187 · see citing works
Self-citationAikawa, T., Gunn, J. R., Spong, S. M., Klaus, S. J., & Korc, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0516 · Cited by 156 · see citing works
Dornhöfer, N., Spong, S. M., Bennewith, K. L., Salim, A., Klaus, S. J., Kambham, N., Wong, C., Kaper, F., Sutphin, P. D., Nacalumi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0081 · Cited by 144 · see citing works
Bennewith, K. L., Huang, X., Ham, C. M., Graves, E. E., Erler, J. T., Kambham, N., Feazell, J., Yang, G. P., Koong, A. C., & Giaccia, A. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0987 · Cited by 142 · see citing works
CXC‐chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Matsuo, Y., Raimondo, M., Woodward, T. A., Wallace, M. B., Gill, K. R., Tong, Z., Burdick, M. D., Yang, Z., Strieter, R. M., Hoffman, R. M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24383 · Cited by 138 · see citing works
Bierie, B., Chung, C. H., Parker, J. S., Stover, D. G., Cheng, N., Chytil, A. M., Aakre, M. E., Shyr, Y., & Moses, H. L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37480 · Cited by 134 · see citing works
Self-citationMatsuo, Y., Campbell, P. M., Brekken, R. A., Sung, B., Ouellette, M. M., Fleming, J. B., Aggarwal, B. B., Der, C. J., & Guha, S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0577 · Cited by 91 · see citing works
Wagner, M., Kleeff, J. H., Frieß, H., Büchler, M. W., & Korc, M. (1999) · Pancreas · doi:10.1097/00006676-199911000-00008 · Cited by 83 · see citing works
Effect of Matrix Metalloproteinase Inhibition on Pancreatic Cancer Invasion and Metastasis
Jimenez, R. E., Hartwig, W., Antoniu, B. A., Compton, C. C., Warshaw, A. L., & Castillo, C. F.-D. (2000) · Annals of Surgery · doi:10.1097/00000658-200005000-00004 · Cited by 66 · see citing works
Venkatasubbarao, K., Ahmed, M. M., Mohiuddin, M., Swiderski, C. F., Lee, E., Gower, W. R., Salhab, K. F., McGrath, P. C., Strodel, W. E., & Freeman, J. W. (2000) · PubMed · Cited by 45 · see citing works
Ruiz, P. A., Shkoda, A., Kim, S. C., Sartor, R. B., & Haller, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.023 · Cited by 45 · see citing works
Adrián, K., Strouch, M. J., Zeng, Q., Barron, M. R., Cheon, E. C., Honasoge, A. P., Xu, Y., Phukan, S., Sadim, M. S., Bentrem, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1705 · Cited by 30 · see citing works
Shier, M. K., Neely, E. B., Ward, M. G., Richards, M. E., Manders, E. C., Meyers, C., & Howett, M. K. (1999) · PubMed · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639 · see citing works
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 2,040 · see citing works
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085 · see citing works
Sherman, M. H., Yu, R. T., Engle, D. D., Ding, N., Atkins, A. R., Tiriac, H., Collisson, E. A., Connor, F., Van Dyke, T., Kozlov, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.007 · Cited by 1,158 · see citing works
The roles of TGFβ in the tumour microenvironment
Pickup, M. W., Novitskiy, S. V., & Moses, H. L. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3603 · Cited by 915 · see citing works
Self-citationSteele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P. J., Upstill‐Goddard, R., Rishi, L., Foth, M., Bryson, S., McDaid, K., Wilson, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.014 · Cited by 850 · see citing works
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Kim, J., & Bae, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/6058147 · Cited by 803 · see citing works
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Ha, H., Debnath, B., & Neamati, N. (2017) · Theranostics · doi:10.7150/thno.15625 · Cited by 788 · see citing works
Neutrophils in cancer: heterogeneous and multifaceted
Hedrick, C. C., & Malanchi, I. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00571-6 · Cited by 778 · see citing works
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Adamska, A., Domenichini, A., & Falasca, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071338 · Cited by 601 · see citing works
Laklai, H., Miroshnikova, Y. A., Pickup, M. W., Collisson, E. A., Kim, G., Barrett, A., Hill, R. C., Lakins, J. N., Schlaepfer, D. D., Mouw, J. K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4082 · Cited by 598 · see citing works
Self-citationPancreatic cancer: from state-of-the-art treatments to promising novel therapies
Garrido‐Laguna, I., & Hidalgo, M. M. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.53 · Cited by 565 · see citing works
Platelets guide the formation of early metastatic niches
Labelle, M., Begum, S., & Hynes, R. O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411082111 · Cited by 555 · see citing works
The current state of the art and future trends in RAS-targeted cancer therapies
Punekar, S. R., Velcheti, V., Neel, B. G., & Wong, K.-K. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00671-9 · Cited by 549 · see citing works
TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
Principe, D. R., Doll, J. A., Bauer, J. I., Jung, B., Munshi, H. G., Bartholin, L., Pasche, B., Lee, C., & Grippo, P. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt369 · Cited by 523 · see citing works
Katoh, H., Wang, D., Daikoku, T., Sun, H., Dey, S. K., & DuBois, R. N. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.009 · Cited by 477 · see citing works
A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment
Apte, M. V., Wilson, J. S., Lugea, A., & Pandol, S. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.11.037 · Cited by 449 · see citing works
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Binenbaum, Y., Na’ara, S., & Gil, Z. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.002 · Cited by 414 · see citing works
Mace, T. A., Ameen, Z., Collins, A., Wojcik, S. E., Mair, M., Young, G. S., Fuchs, J. R., Eubank, T. D., Frankel, W. L., Bekaii‐Saab, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4601 · Cited by 413 · see citing works
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer
Halbrook, C. J., & Lyssiotis, C. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.006 · Cited by 394 · see citing works
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
Jamieson, T., Clarke, M., Steele, C. W., Samuel, M. S., Neumann, J., Jung, A., Huels, D., Olson, M. F., Das, S., Nibbs, R. J. B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61067 · Cited by 391 · see citing works
Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369 · see citing works
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Cheng, Y., Ma, X., Wei, Y.-Q., & Wei, X. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.005 · Cited by 343 · see citing works
Binenbaum, Y., Fridman, E., Yaari, Z. A., Milman, N., Schroeder, A., David, G. B., Shlomi, T., & Gil, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0124 · Cited by 339 · see citing works
Lee, Y. S., Choi, I., Ning, Y., Kim, N., Khatchadourian, V., Yang, D., Chung, H. K., Choi, D., LaBonte, M. J., Ladner, R. D., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.177 · Cited by 292 · see citing works
Neutrophils in innate and adaptive immunity
Jaillon, S., Galdiero, M. R., Prete, D. D., Cassatella, M. A., Garlanda, C., & Mantovani, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0374-8 · Cited by 284 · see citing works
Angiogenesis in pancreatic cancer: current research status and clinical implications
Li, S., Xu, H., Wu, C., Wang, W.-Q., Jin, W., Gao, H.-L., Li, H., Zhang, S.-R., Xu, J.-Z., Qi, Z.-H., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9645-2 · Cited by 285 · see citing works
Cancer Inflammation and CytokinesPreprint
Galdiero, M. R., Marone, G., & Mantovani, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028662 · Cited by 267 · see citing works
El-Kenawi, A., & El‐Remessy, A. B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12344 · Cited by 252 · see citing works
Neeße, A., Frese, K. K., Bapiro, T. E., Nakagawa, T., Sternlicht, M. D., Seeley, T. W., Pilarsky, C. P., Jodrell, D. I., Spong, S. M., & Tuveson, D. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300415110 · Cited by 248 · see citing works
Chao, T., Furth, E. E., & Vonderheide, R. H. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0188 · Cited by 248 · see citing works
Heparanase: From basic research to therapeutic applications in cancer and inflammation
Vlodavsky, I., Singh, P., Boyango, I., Gutter-Kapon, L., Elkin, M., Sanderson, R. D., & Ilan, N. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.10.001 · Cited by 237 · see citing works
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 234 · see citing works
CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target
Zhang, W., Wang, H., Sun, M., Deng, X., Wu, X., Ma, Y., Li, M., Shuoa, S. M., You, Q., & Miao, L. (2020) · 癌症：英文版 · doi:10.1002/cac2.12010 · Cited by 239 · see citing works
Sun, X., He, X., Zhang, Y., Hosaka, K., Andersson, P., Wu, J., Wu, J., Xu, J., Du, Q., Hui, X., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322744 · Cited by 233 · see citing works
Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
Cheng, Y., Mo, F., Li, Q., Han, X., Shi, H., Chen, S., Wei, Y., & Wei, X. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01355-1 · Cited by 214 · see citing works
Modeling Pancreatic Cancer with Organoids
Baker, L. A., Tiriac, H., Clevers, H. C., & Tuveson, D. A. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.03.004 · Cited by 212 · see citing works
Regulation and modulation of antitumor immunity in pancreatic cancer
Leinwand, J., & Miller, G. (2020) · Nature Immunology · doi:10.1038/s41590-020-0761-y · Cited by 205 · see citing works
The immune network in pancreatic cancer development and progression
Wörmann, S. M., Diakopoulos, K. N., Lesina, M., & Algül, H. (2013) · Oncogene · doi:10.1038/onc.2013.257 · Cited by 202 · see citing works
Heßmann, E., Patzak, M. S., Klein, L., Chen, N., Kari, V., Ramu, I., Bapiro, T. E., Frese, K. K., Gopinathan, A., Richards, F. M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311954 · Cited by 202 · see citing works
Tumor stroma as targets for cancer therapy
Zhang, J., & Liu, J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.003 · Cited by 185 · see citing works
Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Ueha, S., Shand, F. H. W., & Matsushima, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00071 · Cited by 185 · see citing works
Genetically engineered mouse models of pancreatic adenocarcinoma
Guerra, C. E., & Barbacid, M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.002 · Cited by 179 · see citing works
Pancreatic cancer: Stroma and its current and emerging targeted therapies
Kota, J., Hancock, J., Kwon, J. J., & Korc, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.12.035 · Cited by 171 · see citing works
What We Have Learned About Pancreatic Cancer From Mouse Models
Pérez-Mancera, P. A., Guerra, C. E., Barbacid, M., & Tuveson, D. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.002 · Cited by 173 · see citing works
CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer
Korbecki, J., Kupnicka, P., Chlubek, M., Gorący, J., Gutowska, I., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042168 · Cited by 168 · see citing works
Saintigny, P., Massarelli, E., Lin, S. H., Ahn, Y., Chen, Y., Goswami, S., Erez, B., O’Reilly, M. S., Liu, D., Lee, J. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0263 · Cited by 165 · see citing works
Liang, C., Shi, S., Meng, Q., Liang, D., Ji, S., Zhang, B., Qin, Y., Xu, J., Ni, Q., & Yu, X. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.255 · Cited by 160 · see citing works
Roles of neutrophils in cancer growth and progression
Galdiero, M. R., Varricchi, G., Loffredo, S., Mantovani, A., & Marone, G. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0717-292r · Cited by 155 · see citing works
Korbecki, J., Barczak, K., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020792 · Cited by 155 · see citing works
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
Grabner, B., Schramek, D., Mueller, K. M., Moll, H. P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7285 · Cited by 143 · see citing works
Genetically Engineered Mouse Models of Pancreatic Cancer
Westphalen, C. B., & Olive, K. P. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827ab4c4 · Cited by 140 · see citing works
Targeting Pancreatic Stellate Cells in Cancer
Schnittert, J., Bansal, R., & Prakash, J. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.01.001 · Cited by 139 · see citing works
Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcène, A., Bianchi, E., Gofflot, S., Drion, P. V., Trombino, G. E., Valentin, E. D., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001871 · Cited by 133 · see citing works
Chronic pancreatitis: A path to pancreatic cancer
Pinho, A. V., Chantrill, L. A., & Rooman, I. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.015 · Cited by 132 · see citing works
Kenkel, J. A., Tseng, W. W., Davidson, M. G., Tolentino, L. L., Choi, O., Bhattacharya, N., Seeley, E. S., Winer, D. A., Reticker-Flynn, N. E., & Engleman, E. G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2212 · Cited by 133 · see citing works
Lesina, M., Wörmann, S. M., Morton, J. P., Diakopoulos, K. N., Korneeva, O., Wimmer, M., Einwächter, H., Sperveslage, J., Demir, İ. E., Kehl, T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86477 · Cited by 128 · see citing works
Neutrophil dynamics in the tumor microenvironment
McFarlane, A. J., Fercoq, F., Coffelt, S. B., & Carlin, L. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143759 · Cited by 129 · see citing works
Pancreatic cancer and its stroma: A conspiracy theory
Xu, Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11216 · Cited by 125 · see citing works
Senescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes
Wang, T., Notta, F., Navab, R., Joseph, J., Ibrahimov, E., Xu, J., Zhu, C.-Q., Borgida, A., Gallinger, S., & Tsao, M.-S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0192 · Cited by 123 · see citing works
Zhou, Z., Xia, G., Xiang, Z., Liu, M., Wei, Z., Yan, J., Chen, W., Zhu, J., Awasthi, N., Sun, X., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3567 · Cited by 123 · see citing works
Ion channels and transporters in tumour cell migration and invasion
Schwab, A., & Stock, C. M. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0102 · Cited by 122 · see citing works
Key role of pancreatic stellate cells in pancreatic cancer
Pothula, S. P., Xu, Z., Goldstein, D., Pirola, R. C., Wilson, J. S., & Apte, M. V. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.035 · Cited by 120 · see citing works
Lv, M., Xu, Y., Tang, R., Ren, J., Shen, S., Chen, Y., Liu, B., Hou, Y., & Wang, T. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0448 · Cited by 116 · see citing works
Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target
Hartupee, C. D., Nagalo, B. M., Chabu, C. Y., Tesfay, M. Z., Coleman‐Barnett, J., West, J. T., & Moaven, O. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1287459 · Cited by 109 · see citing works
Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
Heinrich, M. A., Mostafa, A. M. R. H., Morton, J. P., Hawinkels, L. J. A. C., & Prakash, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.018 · Cited by 110 · see citing works
Liot, S., Balas, J., Aubert, A., Prigent, L., Mercier‐Gouy, P., Verrier, B., Bertolino, P., Hennino, A., Valcourt, U., & Lambert, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612271 · Cited by 106 · see citing works
Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression
Wilson, J. S., Pirola, R. C., & Apte, M. V. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00052 · Cited by 105 · see citing works
Phagocytes as Corrupted Policemen in Cancer-Related Inflammation
Bonavita, E., Galdiero, M. R., Jaillon, S., & Mantovani, A. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.013 · Cited by 100 · see citing works
TGF-β and αvβ6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression
Hezel, A. F., Deshpande, V., Zimmerman, S. M., Contino, G., Alagesan, B., O’Dell, M. R., Rivera, L. B., Harper, J. W., Lonning, S. M., Brekken, R. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0634 · Cited by 99 · see citing works
Wei, Z.-W., Xia, G., Wu, Y., Chen, W., Xiang, Z., Schwarz, R. E., Brekken, R. A., Awasthi, N., He, Y.-L., & Zhang, C.-H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.033 · Cited by 97 · see citing works
Sano, M., Ijichi, H., Takahashi, R., Miyabayashi, K., Fujiwara, H., Yamada, T., Kato, H., Nakatsuka, T., Tanaka, Y., Tateishi, K., et al. (2019) · Oncogenesis · doi:10.1038/s41389-018-0117-8 · Cited by 97 · see citing works
Self-citationStroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Jiang, B., Zhou, L., Lü, J., Wang, Y., Liu, C., You, L., & Guo, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.576399 · Cited by 96 · see citing works
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
Thyagarajan‐Sahu, A., Alshehri, M. S. A., Miller, K. L., Sherwin, C. M. T., Travers, J. B., & Sahu, R. P. (2019) · Cancers · doi:10.3390/cancers11111627 · Cited by 90 · see citing works
Meng, F., Li, W., Li, C., GAO, Z., Guo, K., & Song, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2794 · Cited by 89 · see citing works
Bijlsma, M. F., & van Laarhoven, H. W. M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9541-1 · Cited by 85 · see citing works
The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment
Lafaro, K. J., & Melstrom, L. G. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.09.009 · Cited by 82 · see citing works
Macrophage Polarization in Pancreatic Carcinoma: Role of Heparanase Enzyme
Hermano, E., Meirovitz, A., Meir, K. S., Nussbaum, G., Appelbaum, L., Peretz, T., & Elkin, M. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju332 · Cited by 81 · see citing works
Yan, H. H., Jiang, J. D., Pang, Y., Achyut, B. R., Lizardo, M. M., Liang, X., Hunter, K. W., Khanna, C., Hollander, C. M., & Li, Y. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2282-t · Cited by 81 · see citing works
Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties
Novitskiy, S. V., Pickup, M. W., Chytil, A., Polosukhina, D., Owens, P., & Moses, H. L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211639 · Cited by 79 · see citing works
Self-citationPancreatic stellate cells: Aiding and abetting pancreatic cancer progression
Pothula, S. P., Pirola, R. C., Wilson, J. S., & Apte, M. V. (2020) · Pancreatology · doi:10.1016/j.pan.2020.01.003 · Cited by 78 · see citing works
Achyut, B. R., Bader, D. A., Robles, A. I., Wangsa, D., Harris, C. C., Ried, T., & Yang, H. H. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003251 · Cited by 77 · see citing works
Exploiting inflammation for therapeutic gain in pancreatic cancer
Steele, C. W., Jamieson, N. B., Evans, T. R. J., McKay, C. J., Sansom, O. J., Morton, J. P., & Carter, C. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.24 · Cited by 77 · see citing works
Bohrer, L. R., & Schwertfeger, K. L. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0275 · Cited by 74 · see citing works
Support of Tumor Endothelial Cells by Chemokine Receptors
Salazar, N., & Zabel, B. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00147 · Cited by 72 · see citing works
Desurmont, T., Skrypek, N., Duhamel, A., Jonckheere, N., Millet, G., Leteurtre, E., Gosset, P., Duchêne, B., Ramdane, N., Hebbar, M., et al. (2015) · Cancer Science · doi:10.1111/cas.12603 · Cited by 73 · see citing works
Fokas, E., O’Neill, E., Gordon-Weeks, A. N., Mukherjee, S., McKenna, W. G., & Muschel, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.12.001 · Cited by 71 · see citing works
The pancreatic cancer microenvironment: A true double agent
Melstrom, L. G., Salazar, M. D., & Diamond, D. J. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24643 · Cited by 71 · see citing works
The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis
Bie, Y.-Q., Ge, W., Yang, Z., Cheng, X., Zhao, Z., Li, S., Wang, W., Wang, Y., Zhao, X., Yin, Z.-F., et al. (2019) · Disease Markers · doi:10.1155/2019/8023460 · Cited by 70 · see citing works
RetractedGold Nanoparticle Transforms Activated Cancer-Associated Fibroblasts to Quiescence
Hossen, M. N., Rao, G., Dey, A., Robertson, J. D., Bhattacharya, R., & Mukherjee, P. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03313 · Cited by 70 · see citing works
CXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma
Awaji, M. I., Saxena, S., Wu, L., Prajapati, D. R., Purohit, A., Varney, M. L., Sushil Kumar, K., Rachagani, S., Ly, Q. P., Jain, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902990r · Cited by 69 · see citing works
Zhang, Y., Davis, C., Ryan, J. C., Janney, C., & Peña, M. M. O. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9591-8 · Cited by 67 · see citing works
Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy
Zilio, S., & Serafini, P. (2016) · Vaccines · doi:10.3390/vaccines4030031 · Cited by 66 · see citing works
Wells, J. E., Howlett, M., Cole, C., & Kees, U. R. (2014) · International Journal of Cancer · doi:10.1002/ijc.28972 · Cited by 66 · see citing works
Experimental models of pancreatic cancer desmoplasia
Suklabaidya, S., Dash, P., Das, B., Suresh, V., Sasmal, P. K., & Senapati, S. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.127 · Cited by 65 · see citing works
Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2)
Charrier, A., & Brigstock, D. R. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.07.001 · Cited by 64 · see citing works
Yang, T., Deng, Z., Xu, L., Li, X., Tan, Y., Qian, Y., Lü, Y., Tian, L., Yao, W., & Wang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02235-8 · Cited by 63 · see citing works
Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1
Kishikawa, T., Otsuka, M., Yoshikawa, T., Ohno, M., Ijichi, H., & Koike, K. (2016) · Nature Communications · doi:10.1038/ncomms13006 · Cited by 45 · see citing works
Self-citationLee, Y.-C., Gajdošik, M. Š., Josić, D., Clifton, J. G., Logothetis, C. J., Yu‐Lee, L., Gallick, G. E., Maity, S. N., & Lin, S.-H. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.039909 · Cited by 60 · see citing works
Sano, M., Takahashi, R., Ijichi, H., Ishigaki, K., Yamada, T., Miyabayashi, K., Kimura, G., Mizuno, S., Kato, H., Fujiwara, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320608 · Cited by 56 · see citing works
Self-citation
- Authors
- Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., Mohri, D., Miyabayashi, K., Asaoka, Y., Maeda, S., Ikenoue, T., Tateishi, K., Wright, C. V. E., Koike, K., Omata, M., & Moses, H. L.
- Affiliations
- The University of Tokyo (JP)
- Vanderbilt University (US)
- Whitehead Institute for Biomedical Research (US)
- Chiba University (JP)
- Yokohama City University (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Yamanashi Prefectural Central Hospital (JP)
- Corresponding author
- Ijichi, Hideaki
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-10-03
- Volume
- 121
- Issue
- 10
- Pages
- 4106-4117
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3195452
- OpenAlex
- W2014434319
- Cited by
- 256
- References
- 50
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 8 · 2023: 9 · 2022: 13 · 2021: 31 · 2020: 19 · 2019: 17 · 2018: 7 · 2017: 20 · 2016: 20 · 2015: 20 · 2014: 22 · 2013: 27 · 2012: 24
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Vanderbilt University
- Ministry of Education, Culture, Sports, Science and Technology
- Foundation for Promotion of Cancer Research
- National Institutes of Health
- U.S. Public Health Service (U54126505)
- Japan Society for the Promotion of Science (23591011, 22501004)
- National Cancer Institute (CA 085492, R01CA085492, CA102162, R01CA102162)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Keywords
- pancreatic ductal adenocarcinoma, tumor-stroma interactions, connective tissue growth factor, CXCR2, CXCL chemokines, desmoplasia, TGFBR2, tumor angiogenesis, tumor growth, overall survival, pancreatic intraepithelial neoplasia
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type II, Animals, Female, Humans, Mice, Inbred C57BL, Mice, Nude, Pancreatic Neoplasms, Signal Transduction, Gene Expression, Proto-Oncogene Proteins p21(ras), Stromal Cells, Protein Serine-Threonine Kinases, Receptors, Transforming Growth Factor beta, Mice, Knockout, Chemokines, CXC, Carcinoma, Pancreatic Ductal, Receptors, Interleukin-8B, Mice, Connective Tissue Growth Factor, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
